Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian A Gordon

Showing results (261-270 of 262) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 262 results.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU TrialRandall J Bateman, Yan Li, Eric M McDade, et al.
Brain : a Journal of Neurology|August 14, 2025
Connectivity as a universal predictor of tau progression in atypical Alzheimer's diseaseHannah de Bruin, Colin Groot, Henryk Barthel, et al.
Pageof 27

Showing results (261-270 of 262) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 262 results.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU TrialRandall J Bateman, Yan Li, Eric M McDade, et al.
Brain : a Journal of Neurology|August 14, 2025
Connectivity as a universal predictor of tau progression in atypical Alzheimer's diseaseHannah de Bruin, Colin Groot, Henryk Barthel, et al.
Pageof 27